Rapid Biosafety Testing Adoption PathoQuest's focus on Next-Generation Sequencing-based biosafety testing positions it as a leader in fast, animal-free quality control solutions, making it an appealing partner for biotechs and pharma companies seeking compliant and efficient release processes.
Strategic Industry Collaborations Partnership with Oxford Nanopore Technologies and recent investments indicate a commitment to advancing biosafety technologies, highlighting opportunities to collaborate on innovative testing platforms and expand client solutions.
Expanding Infrastructure The recent $10M investment in new facilities demonstrates growth readiness, creating opportunities to upsell enhanced biosafety testing services and attract manufacturers of advanced biologics looking for scalable, validated testing solutions.
Leadership Expansion New senior hires, including Chief Commercial Officers and Operations Heads, suggest a focus on market expansion and client acquisition, offering potential for tailored sales approaches to biotech firms and biologics manufacturers.
Market Position & Revenue With revenue between $10M and $25M and a specialized niche in biosafety testing, PathoQuest presents opportunities to target mid-sized biotech and gene therapy developers seeking next-gen, GMP-compliant testing services.
$1B$10B
$1M
$1M$10M
$1M$10M
$50M$100M
$10M$25M
$10M$25M
$1M$10MPathoQuest uses 8 technology products and services including Amazon EC2, MySQL, Google Fonts API, and more. Explore PathoQuest's tech stack below.
| PathoQuest Email Formats | Percentage |
| First.Last@pathoquest.com | 83% |
| FLast@pathoquest.com | 14% |
| First.Middle@pathoquest.com | 2% |
| FirstLast@pathoquest.com | 1% |
Biotechnology ResearchFrance51-200 Employees
Your GMP Next-Gen Biosafety Partner. Compliant, Faster, Animal-Free. PathoQuest is a global CRO providing NGS-based Biosafety Quality Control through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients. Validated and accepted GMP assays for viral safety and genetic characterization of raw materials, cell and gene therapies, mAbs & vaccines. Testing available in Paris (France) and in Wayne PA.
Company Overview
Media & News
Funding & FinancialsPathoQuest has raised a total of $17M of funding over 6 rounds. Their latest funding round was raised on Nov 09, 2021 in the amount of $17M.
PathoQuest's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsPathoQuest has raised a total of $17M of funding over 6 rounds. Their latest funding round was raised on Nov 09, 2021 in the amount of $17M.
PathoQuest's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com